Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions

NCT: NCT07730359 · RECRUITING

NCT IDNCT07730359
StatusRECRUITING
Start Date2026-07-06
Completion2027-01-31
SponsorMintech Bio Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

Mintech-Bio Ltd is a UK-based start-up company which was created to turn 14 years of research from our co-founder Dr Alvaro Mata at Queen Mary University into a real-world product. Loss of tooth enamel from issues such as decay or erosion is a great cause of dental problems, affecting over half of people around the world. There is also evidence to suggest that having poor oral health may be connected to other health issues such as diabetes, heart problems, and lung infections like pneumonia. While treatments like fluoride varnishes and remineralization solutions can help with the effects of enamel loss, there's currently no easy-to-use option that actually regrows enamel in a way that closely matches the natural look and strength of real enamel. Mintech-Bio has created a special gel that helps rebuild tooth enamel back to its natural strength and structure. This new invention could take the place of fluoride treatments and make a big difference in preventing tooth problems around the world. The purpose of this research study is to demonstrate the efficacy of the Epinamel device in the treatment of dental white-spot lesions. If you meet all the screening criteria you will be entered into the study and shall have the device applied after the removal of dental braces. Each trial participant will have the treatment product applied to a tooth on one side of the mouth, and a comparative 'control' product named Curodont Repair (vVardis Professional, Switzerland will be applied on the opposite side of the mouth.

Frequently Asked Questions

What is Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions?

Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions is a clinical trial registered under NCT07730359. Current status: RECRUITING.

What is the status of NCT07730359?

The current status of NCT07730359 (Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions) is: RECRUITING.

When did Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions start?

Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions started on 2026-07-06.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.